We sit down with you and build your perfect lead list. Book a call with founders.

Digistain Analysis

What is Digistain?

Digistain offers an AI-enabled tumor profiling test to evaluate breast cancer recurrence risk, facilitating personalized treatment decisions for patients post-surgery.

Employees
40
Founded
2019
Revenue
$2.3M
Company Stage
Seed
Investors
- Sofia Angels Ventures
YC Batch
S21

Product Features & Capabilities

  • tumour profiling technology, Digistain Prognostic Score, predicts 10-year risk of recurrence, personalized treatment plans, results in under 1 hour, lower costs, seamless integration with clinical workflows

Who are the founders of Digistain

Find more companies like Digistain

in Y Combinator batch S21 companies

Financial Overview

$2.3MEstimated Revenue
Seed
August 2021
Investors: Y Combinator
Want to research more data points on Digistain?
Start with Extruct